Analyst Ratings for Colgate-Palmolive Company (CL)
CL Rating Summary
CL Price Target Summary
- Highest: $122.00 (Goldman Sachs)
- Lowest: $95.00 (Citi)
- Average: $108.29
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$108.29 (+75.8%)
Avg. $ Target:
$108.29 (+75.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/25/2013 | Barclays | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
117.90 | 61.58 | -47.77% | Details |
| 3/15/2013 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
113.84 | 61.58 | -45.91% | Details |
| 2/26/2013 | BofA/Merrill Lynch | Downgrade | Neutral (Buy) |
N/A (N/A) |
114.01 | 61.58 | -45.99% | Details |
| 2/14/2013 | Canaccord Genuity | New Coverage | Sell (N/A) |
102.00 (N/A) |
107.90 | 61.58 | -42.93% | Details |
| 1/24/2013 | Credit Suisse | New Coverage | Outperform (N/A) |
N/A (N/A) |
108.81 | 61.58 | -43.41% | Details |
| 12/14/2012 | Goldman Sachs | New Coverage | Neutral (N/A) |
122.00 (N/A) |
106.16 | 61.58 | -41.99% | Details |
| 7/30/2012 | Buckingham Research | Upgrade | Buy (Neutral) |
120.00 (N/A) |
107.17 | 61.58 | -42.54% | Details |
| 7/27/2012 | Deutsche Bank | Downgrade | Hold (Buy) |
110.00 (105.00) |
106.38 | 61.58 | -42.11% | Details |
| 5/15/2012 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
99.01 | 61.58 | -37.8% | Details |
| 3/19/2012 | Credit Agricole | Upgrade | Outperform (N/A) |
105.00 (N/A) |
94.79 | 61.58 | -35.04% | Details |
| 9/28/2011 | Citi | Downgrade | Neutral (N/A) |
95.00 (N/A) |
91.07 | 61.58 | -32.38% | Details |
| 6/10/2011 | CLSA » Updated 6/10/2011 |
Downgrade | Sell (N/A) |
N/A (N/A) |
85.10 | 61.58 | -27.64% | Details |
| 2/16/2011 | Weeden & Co | New Coverage | Hold (N/A) |
N/A (N/A) |
78.24 | 61.58 | -21.29% | Details |
| 1/20/2011 | Wells Fargo | New Coverage | Market Perform (N/A) |
N/A (N/A) |
79.00 | 61.58 | -22.05% | Details |
| 1/5/2011 | UBS » Updated 7/27/2012 |
Downgrade | Neutral (N/A) |
104.00 (98.00) |
79.68 | 61.58 | -22.72% | Details |
